In today’s recent session, 25.24 million shares of the AC Immune SA (NASDAQ:ACIU) have been traded, and its beta is 1.10. Most recently the company’s share price was $3.06, and it changed around $0.75 or 32.47% from the last close, which brings the market valuation of the company to $303.55M. ACIU at last check was trading at a discount to its 52-week high of $5.14, offering almost -67.97% off that amount. The share price’s 52-week low was $1.90, which indicates that the recent value has risen by an impressive 37.91% since then. We note from AC Immune SA’s average daily trading volume that its 3-month average coming to 182.76K.
AC Immune SA stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended ACIU as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. AC Immune SA is expected to report earnings per share of -$0.15 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
AC Immune SA (NASDAQ:ACIU) trade information
Instantly ACIU has been showing a green trend so far today with a performance of 32.47% on intraday trading today. The performance over the last five days has remained in the green territory. The company’s shares are currently down -38.80% year-to-date, but still up 27.50% over the last five days. On the other hand, AC Immune SA (NASDAQ:ACIU) is 11.68% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $10, which translates to bulls needing to increase their stock price by 69.4% from its current value. Analyst projections state that ACIU is forecast to be at a low of $10 and a high of $10.
AC Immune SA (ACIU) estimates and forecasts
AC Immune SA share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 2.68 percent over the past six months and at a -4.23% annual growth rate that is well below the industry average of 12.90%. The year-over-year growth rate is expected to be -42.70%, down from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of $6.05 million in revenue for the current quarter. 2 analysts expect AC Immune SA to make $550k in revenue for the quarter ending Jun 2024. The company’s sales for a year ago were $1.84 million respectively. Forecasts for the next quarter put sales growth at -70.10%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 3.28%.
